Long-term Cardiovascular Risk in Cured Cushing's Patients
NCT00881283 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2020-09-02
Summary
The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.
Conditions
- Cushing's Disease
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Anne Klibanski, MD · Massachusetts General Hospital
Eligibility
- Min Age
- 35 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-08
- Primary Completion
- 2010-03-30
- Completion
- 2010-03-30
Countries
- United States
Study Locations
More Related Trials
-
Open-label Treatment in Cushing's Syndrome
NCT03621280 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
NCT00182091 ·Status: COMPLETED ·Phase: NA
-
Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
NCT00171951 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
NCT02922257 ·Status: COMPLETED
-
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
NCT01915303 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Depression, Peptides, and Steroids in Cushing's Syndrome
NCT00004334 ·Status: UNKNOWN
-
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
NCT02804750 ·Status: COMPLETED ·Phase: PHASE2
-
The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases
NCT03575247 ·Status: COMPLETED
-
Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
NCT00682084 ·Status: TERMINATED
-
Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
NCT01807364 ·Status: COMPLETED
-
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
NCT00612066 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
NCT00004343 ·Status: UNKNOWN
-
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
NCT00434148 ·Status: COMPLETED ·Phase: PHASE3
-
Genomic and Metabolomic Markers Reflecting the Complications of Hypercortisolism (CUSHINGOMICS)
NCT04840693 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome
NCT06801249 ·Status: RECRUITING ·Phase: PHASE4
-
Preoperative Bexarotene Treatment for Cushing's Disease
NCT00845351 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation
NCT00688987 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
NCT01421589 ·Status: COMPLETED ·Phase: NA
-
Muscle in Acromegaly and Cushing's Syndrome
NCT03673761 ·Status: UNKNOWN
-
The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis
NCT02791698 ·Status: UNKNOWN
-
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
NCT00646308 ·Status: TERMINATED
-
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
NCT06471829 ·Status: RECRUITING ·Phase: PHASE2
-
Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
NCT01246739 ·Status: TERMINATED ·Phase: NA
-
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
NCT03604198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Treatment and Natural History of Acromegaly
NCT00001981 ·Status: COMPLETED